Clinical Trial Update: A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

This is a Phase I/II, single-arm, open-label study of ofatumumab in patients with previously treated chronic lymphocytic leukemia, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Arzerra (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2012-01-27